NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibitionYiannis Drosos, Charles W.M. Roberts, Jacquelyn Myers et al.|Molecular Cell|2022Cited by 53
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A. Upadhyaya, Amar Gajjar, Arzu Onar‐Thomas et al.|Neuro-Oncology|2022Cited by 29